HomeSYNACT • STO
add
SynAct Pharma AB
Previous close
kr 16.15
Day range
kr 15.80 - kr 17.08
Year range
kr 6.14 - kr 19.69
Market cap
809.14M SEK
Avg Volume
246.84K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 20.80M | 26.77% |
Net income | -18.38M | 79.70% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.15M | -196.05% |
Effective tax rate | 9.54% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 61.21M | -1.90% |
Total assets | 270.52M | 18.64% |
Total liabilities | 56.35M | 8.72% |
Total equity | 214.17M | — |
Shares outstanding | 49.01M | — |
Price to book | 3.50 | — |
Return on assets | -21.32% | — |
Return on capital | -26.89% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -18.38M | 79.70% |
Cash from operations | -17.78M | 12.83% |
Cash from investing | — | — |
Cash from financing | 40.20M | -26.32% |
Net change in cash | 22.72M | -32.21% |
Free cash flow | -7.83M | -112.63% |
About
Founded
Mar 14, 2012
Website
Employees
6
